See also
this year's filing and
all EDGAR filings for this company.
PDF Report 0000722104_2012_Savient_Pharmaceuticals_INC.pdf
Logs
| warning |
The stock price does not exist |
industry.us_generic |
{} |
| warning |
Missing logo |
subcommand.report |
{} |
| info |
Failed to set obs_EconomicCapitalRatio |
industry.us_generic |
{'reason': "KeyError('0000722104')"} |
| info |
Added remainder_ComprehensiveNetIncome directly from 10K |
industry.us_generic |
{} |
Graph
Absolute values for 0000722104, Savient Pharmaceuticals INC
| |
xvar |
xval |
| 0 |
LiabilitiesNoncurrent |
0 |
| 1 |
LiabilitiesCurrent |
30,065,000 |
| 2 |
remainder_Liabilities |
0 |
| 3 |
AssetsCurrent |
189,635,000 |
| 4 |
AssetsNoncurrent |
2,580,000 |
| 5 |
PropertyPlantAndEquipmentNet |
833,000 |
| 6 |
Goodwill |
0 |
| 7 |
remainder_Assets |
4,068,000 |
| 8 |
GeneralAndAdministrativeExpense |
90,898,000 |
| 9 |
ResearchAndDevelopmentExpense |
24,790,000 |
| 10 |
remainder_Expenses |
-1,738,000 |
| 11 |
remainder_Revenues |
9,565,000 |
| 12 |
remainder_NetIncome |
2,358,000 |
| 13 |
remainder_ComprehensiveNetIncome |
14,000 |
| |
yvar |
yval |
| 0 |
Liabilities |
30,065,000 |
| 1 |
Assets |
197,116,000 |
| 2 |
Expenses |
113,950,000 |
| 3 |
Revenues |
9,565,000 |
| 4 |
StockholdersEquity |
167,051,000 |
| 5 |
NetIncome |
-102,027,000 |
| 6 |
ComprehensiveNetIncome |
-102,020,000 |
| 7 |
BaseVar |
176,534,000 |
| 8 |
EconomicCapitalRatiobeforeLimitedLiability |
1.12 |
| 9 |
EconomicCapitalRatio |
1.76 |
Edgar->Model Mapping
Feature Distribution
Change over Time
